Annual Net Income
-$19.00 M
+$3.26 M+14.65%
December 31, 2024
Summary
- As of February 27, 2025, NVCT annual net profit is -$19.00 million, with the most recent change of +$3.26 million (+14.65%) on December 31, 2024.
- During the last 3 years, NVCT annual net income has fallen by -$6.11 million (-47.40%).
- NVCT annual net income is now -47.40% below its all-time high of -$12.89 million, reached on December 31, 2021.
Performance
NVCT Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
N/A
December 31, 2024
Summary
- NVCT quarterly net profit is not available.
Performance
NVCT Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Net Income
N/A
December 31, 2024
Summary
- NVCT TTM net profit is not available.
Performance
NVCT TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
NVCT Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.7% | - | - |
| 3 y3 years | -47.4% | - | - |
| 5 y5 years | - | - | - |
NVCT Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -47.4% | +14.7% | ||||
| 5 y | 5-year | -47.4% | +14.7% | ||||
| alltime | all time | -47.4% | +14.7% |
Nuvectis Pharma Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$19.00 M(-14.6%) | - | - |
| Sep 2024 | - | -$4.15 M(-6.2%) | -$19.37 M(-8.2%) |
| Jun 2024 | - | -$4.43 M(+6.2%) | -$21.10 M(-5.7%) |
| Mar 2024 | - | -$4.17 M(-37.0%) | -$22.38 M(+0.5%) |
| Dec 2023 | -$22.26 M(+16.6%) | -$6.62 M(+12.6%) | -$22.26 M(-0.3%) |
| Sep 2023 | - | -$5.88 M(+3.0%) | -$22.33 M(+0.0%) |
| Jun 2023 | - | -$5.71 M(+41.0%) | -$22.33 M(+10.6%) |
| Mar 2023 | - | -$4.05 M(-39.5%) | -$20.19 M(+5.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$19.09 M(+48.1%) | -$6.70 M(+13.9%) | -$19.09 M(+30.3%) |
| Sep 2022 | - | -$5.88 M(+64.7%) | -$14.65 M(+9.0%) |
| Jun 2022 | - | -$3.57 M(+21.3%) | -$13.44 M(-15.0%) |
| Mar 2022 | - | -$2.94 M(+30.2%) | -$15.81 M(+22.7%) |
| Dec 2021 | -$12.89 M | -$2.26 M(-51.6%) | -$12.89 M(+21.3%) |
| Sep 2021 | - | -$4.67 M(-21.4%) | -$10.63 M(+78.3%) |
| Jun 2021 | - | -$5.94 M(>+9900.0%) | -$5.96 M(>+9900.0%) |
| Mar 2021 | - | -$23.00 K | -$23.00 K |
FAQ
- What is Nuvectis Pharma annual net profit?
- What is the all time high annual net income for Nuvectis Pharma?
- What is Nuvectis Pharma annual net income year-on-year change?
- What is the all time high quarterly net income for Nuvectis Pharma?
- What is the all time high TTM net income for Nuvectis Pharma?
What is Nuvectis Pharma annual net profit?
The current annual net income of NVCT is -$19.00 M
What is the all time high annual net income for Nuvectis Pharma?
Nuvectis Pharma all-time high annual net profit is -$12.89 M
What is Nuvectis Pharma annual net income year-on-year change?
Over the past year, NVCT annual net profit has changed by +$3.26 M (+14.65%)
What is the all time high quarterly net income for Nuvectis Pharma?
Nuvectis Pharma all-time high quarterly net profit is -$23.00 K
What is the all time high TTM net income for Nuvectis Pharma?
Nuvectis Pharma all-time high TTM net profit is -$23.00 K